Cargando…

Short-term efficacy of abatacept in the treatment of refractory ocular and cutaneous Behçet’s disease

Detalles Bibliográficos
Autores principales:	Maciel, Marcus de Luca, Novello, Marcelo, Neves, Fabricio Souza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649950/ https://www.ncbi.nlm.nih.gov/pubmed/31431944 http://dx.doi.org/10.1093/rap/rkx004

Ejemplares similares

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Lundquist, Lisa M, et al.
Publicado: (2012)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

Ocular involvement in Behçet’s disease: relevance of new diagnostic tools
por: Tinti, Maria Giulia, et al.
Publicado: (2020)

A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy
por: ÇAĞLAYAN, Mehmet, et al.
Publicado: (2020)

Immunopathogenesis of Ocular Behçet's Disease
por: Park, Un Chul, et al.
Publicado: (2014)

Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama, Atsuko, et al.
Publicado: (2019)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

Cytokine Signatures in Mucocutaneous and Ocular Behçet’s Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency
por: Boz, Valentina, et al.
Publicado: (2021)

Abatacept in psoriatic arthritis: Case report and short review
por: Ursini, Francesco, et al.
Publicado: (2013)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Ocular expressions of children behcet disease
por: Chkirate, Bouchra, et al.
Publicado: (2014)

Behcet's Disease: Systemic and Ocular Manifestations
por: Paovic, Jelena, et al.
Publicado: (2013)

Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
por: Tardella, Marika, et al.
Publicado: (2021)

Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study
por: Muraoka, Sei, et al.
Publicado: (2021)

Cytotoxic drugs in ocular lesions of Behçet's disease
por: Davatchi, F, et al.
Publicado: (2003)

Mean Platelet Volume in Ocular Behçet's Disease
por: Türkcü, Fatih Mehmet, et al.
Publicado: (2013)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Lutt, Joseph R
Publicado: (2009)

Neuro-Behcet disease
por: Zhang, Lin, et al.
Publicado: (2021)

Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
por: Desbois, Anne Claire, et al.
Publicado: (2016)

Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet’s Disease and Antiphospholipid Syndrome
por: Guiomar, Verónica, et al.
Publicado: (2019)

Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
por: Köller, Marcus D.
Publicado: (2007)

Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003)

Neuro-Behçet’s syndrome with a severe ocular lesion
por: Han, Dan, et al.
Publicado: (2019)

P29 A case of paediatric ocular Behcet’s
por: McKenna, Dearbhla, et al.
Publicado: (2021)

Advances in pathogenesis and treatment of ocular involvement in Behcet’s disease
por: Lin, Suibin, et al.
Publicado: (2023)

Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan
por: Ohno, Shigeaki, et al.
Publicado: (2019)

SNP algorithms for prediction of efficacy and adverse events of abatacept (ABT)
por: Middleton, James E, et al.
Publicado: (2012)

Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy
por: Kunishita, Yosuke, et al.
Publicado: (2023)

Clinical heterogeneity of ocular Behçet’s syndrome versus intestinal Behçet’s syndrome: a cross-sectional study from Shanghai Behçet’s syndrome database
por: Hou, Cheng-cheng, et al.
Publicado: (2022)

No Family Clustering in Behçet’s Syndrome
por: Tezcan, Mehmet Engin
Publicado: (2019)

Ocular involvement in pediatric Behçet’s disease: is it different than in adults? (a short case series and mini review)
por: Azri, Casem, et al.
Publicado: (2023)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
por: Zou, Jun, et al.
Publicado: (2022)

Fluorescein angiographic findings and Behcet's disease ocular attack score 24 (BOS24) as prognostic factors for visual outcome in patients with ocular Behcet's disease
por: Keorochana, Narumon, et al.
Publicado: (2021)

Efficacy of infliximab in neuro-Behçet’s disease presenting with isolated longitudinally extensive transverse myelitis
por: Kuroda, Ryo, et al.
Publicado: (2013)

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
por: Park, Jihye, et al.
Publicado: (2018)

Serum Leptin Levels in Patients with Ocular and Nonocular Behçet's Disease
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2007)

Current trends in the management of ocular symptoms in Adamantiades-Behçet’s disease
por: Zakka, Fouad R, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2i1dbulk6l1ifdasmq6g4vij9j